LivaNova (LIVN) Accumulated Depreciation & Amortization (2014 - 2025)
LivaNova's (LIVN) quarterly Accumulated Depreciation & Amortization came in at $242.2 million in Q4 2025, up 17.15% year-on-year from $206.8 million in Q4 2024, and up 17.15% quarter-over-quarter from $206.8 million in Q4 2024.
LivaNova (LIVN) Accumulated Depreciation & Amortization (2014 - 2025) Analysis & Trends
LivaNova has disclosed Accumulated Depreciation & Amortization across 12 years of filings, most recently posting $242.2 million for Q4 2025.
- Accumulated Depreciation & Amortization for Q4 2025 came in at $242.2 million, up 17.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $242.2 million (up 17.15% YoY), and the FY2025 annual result was $242.2 million, up 17.15% from the prior year.
- Accumulated Depreciation & Amortization came in at $242.2 million for Q4 2025 at LivaNova, up from $206.8 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $242.2 million in Q4 2025 to a low of $161.8 million in Q4 2021.
- The 5-year median for Accumulated Depreciation & Amortization is $196.0 million (2023), against an average of $196.4 million.
- Across the five-year window, Accumulated Depreciation & Amortization climbed 1.99% in 2021 and climbed 17.15% in 2025, its largest moves.
- LivaNova's Accumulated Depreciation & Amortization stood at $161.8 million in 2021, then advanced by 8.24% to $175.1 million in 2022, then grew by 11.94% to $196.0 million in 2023, then gained by 5.47% to $206.8 million in 2024, then rose by 17.15% to $242.2 million in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $242.2 million (Q4 2025), $206.8 million (Q4 2024), and $196.0 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242.21 Mn |
| Dec 31, 2025 | 242.21 Mn |
| Dec 31, 2024 | 206.75 Mn |
| Dec 31, 2024 | 206.75 Mn |
| Dec 31, 2023 | 196.04 Mn |
| Dec 31, 2023 | 196.04 Mn |
| Dec 31, 2022 | 175.12 Mn |
| Dec 31, 2022 | 175.12 Mn |
| Dec 31, 2021 | 161.79 Mn |
| Dec 31, 2021 | 161.79 Mn |
| Dec 31, 2020 | 158.62 Mn |
| Dec 31, 2020 | 158.62 Mn |
| Dec 31, 2019 | 153.99 Mn |
| Dec 31, 2019 | 153.99 Mn |
| Dec 31, 2018 | 130.04 Mn |
| Dec 31, 2018 | 130.04 Mn |
| Dec 31, 2017 | 103.21 Mn |
| Dec 31, 2017 | 103.21 Mn |
| Dec 31, 2016 | 85.36 Mn |
| Dec 31, 2016 | 85.36 Mn |